![Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance - The Lancet Infectious Diseases Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/4a913d00-ad11-4fc5-a0e4-d6954bd1918b/gr1_lrg.jpg)
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance - The Lancet Infectious Diseases
![Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance - The Lancet Infectious Diseases Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/9483d15b-dea1-40ec-a93c-9b6727250524/gr3_lrg.jpg)
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance - The Lancet Infectious Diseases
![Expedited Nuclear Magnetic Resonance Assignment of Small- to Medium-Sized Molecules with Improved HSQC−CLIP−COSY Experiments | Analytical Chemistry Expedited Nuclear Magnetic Resonance Assignment of Small- to Medium-Sized Molecules with Improved HSQC−CLIP−COSY Experiments | Analytical Chemistry](https://pubs.acs.org/cms/10.1021/acs.analchem.0c04124/asset/images/large/ac0c04124_0006.jpeg)